131 related articles for article (PubMed ID: 19201475)
1. rs660 polymorphism in Ro52 (SSA1; TRIM21) is a marker for age-dependent tolerance induction and efficiency of alloimmunization in sickle cell disease.
Tatari-Calderone Z; Minniti CP; Kratovil T; Stojakovic M; Vollmer A; Barjaktarevic I; Zhang E; Hoang A; Luban NL; Vukmanovic S
Mol Immunol; 2009 Nov; 47(1):64-70. PubMed ID: 19201475
[TBL] [Abstract][Full Text] [Related]
2. Red blood cell alloimmunization in sickle cell disease patients in Uganda.
Natukunda B; Schonewille H; Ndugwa C; Brand A
Transfusion; 2010 Jan; 50(1):20-5. PubMed ID: 19821949
[TBL] [Abstract][Full Text] [Related]
3. Red blood cell alloimmunization in sickle cell disease: the influence of racial and antigenic pattern differences between donors and recipients in Brazil.
Moreira Júnior G; Bordin JO; Kuroda A; Kerbauy J
Am J Hematol; 1996 Jul; 52(3):197-200. PubMed ID: 8756087
[TBL] [Abstract][Full Text] [Related]
4. Lower alloimmunization rates in pediatric sickle cell patients on chronic erythrocytapheresis compared to chronic simple transfusions.
Wahl SK; Garcia A; Hagar W; Gildengorin G; Quirolo K; Vichinsky E
Transfusion; 2012 Dec; 52(12):2671-6. PubMed ID: 22519830
[TBL] [Abstract][Full Text] [Related]
5. Antibody development in pediatric sickle cell patients undergoing erythrocytapheresis.
Godfrey GJ; Lockwood W; Kong M; Bertolone S; Raj A
Pediatr Blood Cancer; 2010 Dec; 55(6):1134-7. PubMed ID: 20979172
[TBL] [Abstract][Full Text] [Related]
6. Red blood cell alloimmunization among sickle cell Kuwaiti Arab patients who received red blood cell transfusion.
Ameen R; Al Shemmari S; Al-Bashir A
Transfusion; 2009 Aug; 49(8):1649-54. PubMed ID: 19453992
[TBL] [Abstract][Full Text] [Related]
7. Alloimmunization in sickle cell anemia in the era of extended red cell typing.
O'Suoji C; Liem RI; Mack AK; Kingsberry P; Ramsey G; Thompson AA
Pediatr Blood Cancer; 2013 Sep; 60(9):1487-91. PubMed ID: 23508932
[TBL] [Abstract][Full Text] [Related]
8. High multi-cytokine levels are not a predictive marker of alloimmunization in transfused sickle cell disease patients.
Tatari-Calderone Z; Fasano RM; Miles MR; Pinto LA; Luban NL; Vukmanovic S
Cytokine; 2014 Jul; 68(1):59-64. PubMed ID: 24746244
[TBL] [Abstract][Full Text] [Related]
9. HLA alloimmunization is associated with RBC antibodies in multiply transfused patients with sickle cell disease.
McPherson ME; Anderson AR; Castillejo MI; Hillyer CD; Bray RA; Gebel HM; Josephson CD
Pediatr Blood Cancer; 2010 Apr; 54(4):552-8. PubMed ID: 19890898
[TBL] [Abstract][Full Text] [Related]
10. DNA array analysis for red blood cell antigens facilitates the transfusion support with antigen-matched blood in patients with sickle cell disease.
Ribeiro KR; Guarnieri MH; da Costa DC; Costa FF; Pellegrino J; Castilho L
Vox Sang; 2009 Aug; 97(2):147-52. PubMed ID: 19392786
[TBL] [Abstract][Full Text] [Related]
11. Red cell exchange does not appear to increase the rate of allo- and auto-immunization in chronically transfused children with sickle cell disease.
Venkateswaran L; Teruya J; Bustillos C; Mahoney D; Mueller BU
Pediatr Blood Cancer; 2011 Aug; 57(2):294-6. PubMed ID: 21298771
[TBL] [Abstract][Full Text] [Related]
12. Transfusion management of sickle cell patients during bone marrow transplantation with matched sibling donor.
McPherson ME; Anderson AR; Haight AE; Jessup P; Castillejo MI; Hillyer CD; Josephson CD
Transfusion; 2009 Sep; 49(9):1977-86. PubMed ID: 19453984
[TBL] [Abstract][Full Text] [Related]
13. [Red blood cell immunization in haemoglobinopathie: about 84 cases].
Ben Amor I; Louati N; Khemekhem H; Dhieb A; Rekik H; Mdhaffar M; Gargouri J
Transfus Clin Biol; 2012 Dec; 19(6):345-52. PubMed ID: 23103424
[TBL] [Abstract][Full Text] [Related]
14. Alloimmunization and clinical profile of sickle cell disease patients from Salvador-Brazil.
Dias Zanette AM; de Souza Gonçalves M; Vilasboas Schettini L; Magalhães Aguiar L; Santos Bahia RC; Vasconcelos Nogueira LA; de Freitas Brandão CJ; Neves de Azevedo AC; Ramos de Aragao L; Marcos Arruda S
Ethn Dis; 2010; 20(2):136-41. PubMed ID: 20503893
[TBL] [Abstract][Full Text] [Related]
15. Partial C antigen in sickle cell disease patients: clinical relevance and prevention of alloimmunization.
Tournamille C; Meunier-Costes N; Costes B; Martret J; Barrault A; Gauthier P; Galactéros F; Nzouékou R; Bierling P; Noizat-Pirenne F
Transfusion; 2010 Jan; 50(1):13-9. PubMed ID: 19778340
[TBL] [Abstract][Full Text] [Related]
16. Immunoregulatory networks in sickle cell alloimmunization.
Yazdanbakhsh K
Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):457-461. PubMed ID: 27913516
[TBL] [Abstract][Full Text] [Related]
17. Allosensitization in patients receiving multiple blood transfusions.
Sakhalkar VS; Roberts K; Hawthorne LM; McCaskill DM; Veillon DM; Caldito GC; Cotelingam JD
Ann N Y Acad Sci; 2005; 1054():495-9. PubMed ID: 16339705
[TBL] [Abstract][Full Text] [Related]
18. Delayed hemolytic transfusion reaction in sickle cell disease patients: evidence of an emerging syndrome with suicidal red blood cell death.
Chadebech P; Habibi A; Nzouakou R; Bachir D; Meunier-Costes N; Bonin P; Rodet M; Chami B; Galacteros F; Bierling P; Noizat-Pirenne F
Transfusion; 2009 Sep; 49(9):1785-92. PubMed ID: 19413729
[TBL] [Abstract][Full Text] [Related]
19. Nonclassical
Meinderts SM; Sins JWR; Fijnvandraat K; Nagelkerke SQ; Geissler J; Tanck MW; Bruggeman C; Biemond BJ; Rijneveld AW; Kerkhoffs JH; Pakdaman S; Habibi A; van Bruggen R; Kuijpers TW; Pirenne F; van den Berg TK
Blood; 2017 Nov; 130(19):2121-2130. PubMed ID: 28899854
[TBL] [Abstract][Full Text] [Related]
20. Risk of alloimmunization and delayed hemolytic transfusion reactions in patients with sickle cell disease.
Cox JV; Steane E; Cunningham G; Frenkel EP
Arch Intern Med; 1988 Nov; 148(11):2485-9. PubMed ID: 3142382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]